IL6 and colitis: In a rat model of DSS-induced colitis, the oral administration of Lf induced a significant increase in anti-inflammatory cytokines (IL-4 and IL-10) and a significant reduction in pro-inflammatory cytokines (TNF- α, IL-1β and IL-6), with a consistent improvement in disease severity [74].